Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS
Home/The Filing Wire/Monopar Therapeutics/ 4/A

Changes in Beneficial Ownership · 4/A

Monopar Therapeutics

MNPRNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 28, 2026Accepted Aug 28, 2026, 8:18 PM EDTCIK 1645469Accession 0001437749-26-029235
View company →Permanent SEC source ↗
Share

Company context

Current securities

MNPRNASDAQ · EQUITY · Current

Recent company filings

  1. 144 filingOct 1, 2026
  2. 4/A filingAug 28, 2026
  3. 4 filingAug 27, 2026
  4. 4 filingAug 27, 2026
  5. 4 filingAug 27, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.